2005年

1. Takahashi, M., Nakamura, Y., Obama, K. Furukawa Y. Identification of SP5 as a downstream gene of the beta-catenin/Tcf pathway and its enhanced expression in human colon cancer. International Journal of Oncology 27: 1483-1487, 2005.
2. Tsuge M, Hamamoto R, Silva FP, Ohnishi Y, Chayama K, Kamatani N, Furukawa Y, Nakamura Y. VNTR Polymorphism of E2F-1 binding element in the 5ﾕ flanking region of SMYD3 is a risk factor for human cancers. Nature Genetics 37(10): 1104-1107, 2005.
3. Watanabe T, Suda T, Tsunoda T, Uchida N, Ura K, Kato T, Hasegawa S, Satoh S, Ohgi S, Tahara H, Furukawa Y, Nakamura Y. Identification of Immunoglobulin superfamily 11 (IGSF11) as a novel target for cancer immunotherapy of gastrointestinal and hepatocellular carcinomas. Cancer Science 96(8): 498-506, 2005.
4. Obama K, Ura K, Satoh S, Nakamura Y, Furukawa Y. Up-regulation of PSF2, a member of multiprotein complex GINS, involved in cholangiocarcinogenesis. Oncology Report 14: 701-706, 2005.
5. Silva FP, Hamamoto R, Nakamura Y, Furukawa Y. WDRPUH, a novel WD-repeat containing protein, is highly expressed in human hepatocellular carcinoma and involved in cell proliferation. Neoplasia 7(4): 348-355, 2005.
6. Obama K, Ura K, Li M, Katagiri T, Tsunoda T, Nomura A, Satoh S, Nakamura Y, Furukawa Y. Genome-wide analysis of gene expression in human intrahepatic cholangiocarcinomas. Hepatology 41(6): 1339-1348, 2005.